Th17 cells can provide B cell help in autoantibody induced arthritis

Journal of Autoimmunity

Volumn 36, Issue 1, 2011, Pages 65-75

  Hickman Brecks, Cynthia L ^a   Racz, Jennifer L ^a   Meyer, Debra M ^b   LaBranche, Timothy P ^b   Allen, Paul M ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United States)

Author keywords

Arthritis; Autoantibody; B cell help; IL 17; Th1; Th17

Indexed keywords

AUTOANTIBODY; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; INTERLEUKIN 17; INTERLEUKIN 4; NEUTRALIZING ANTIBODY; TRANSCRIPTION FACTOR T BET;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANKLE; ANTIBODY RESPONSE; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL POLARITY; CHRONIC ARTHRITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; LYMPH NODE; LYMPHOCYTE DIFFERENTIATION; MOUSE; NONHUMAN; POPLITEAL LYMPH NODE; PRIORITY JOURNAL; TH1 CELL; TH17 CELL;

ADOPTIVE TRANSFER; ANIMALS; ANKLE; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-LYMPHOCYTES; CELL SEPARATION; FLOW CYTOMETRY; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; TH1 CELLS; TH17 CELLS;

EID: 79151486080     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2010.10.007     Document Type: Article

References (69)

1. Brennan F.M., Maini R.N., Feldmann M. Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol 1998, 20:133-147.
2. Feldmann M., Brennan F.M., Maini R.N. Rheumatoid arthritis. Cell 1996, 85:307-310.
3. Weissmann G. Pathogenesis of rheumatoid arthritis. J Clin Rheumatol 2004, 10:S26-S31.
4. Kouskoff V., Korganow A.S., Duchatelle V., Degott C., Benoist C., Mathis D. Organ-specific disease provoked by systemic autoimmunity. Cell 1996, 87:811-822.
5. Basu D., Horvath S., Matsumoto I., Fremont D.H., Allen P.M. Molecular basis for recognition of an arthritic peptide and a foreign epitope on distinct MHC molecules by a single TCR. J Immunol 2000, 164:5788-5796.
6. Matsumoto I., Lee D.M., Goldbach-Mansky R., Sumida T., Hitchon C.A., Schur P.H., et al. Low prevalence of antibodies to glucose-6-phosphate isomerase in patients with rheumatoid arthritis and a spectrum of other chronic autoimmune disorders. Arthritis Rheum 2003, 48:944-954.
7. Korganow A.S., Ji H., Mangialaio S., Duchatelle V., Pelanda R., Martin T., et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999, 10:451-461.
8. Matsumoto I., Stab A., Benoist C., Mathis D. Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science 1999, 286:1732-1735.
9. Scatizzi J.C., Bickel E., Hutcheson J., Haines G.K., Perlman H. Bim deficiency leads to exacerbation and prolongation of joint inflammation in experimental arthritis. Arthritis Rheum 2006, 54:3182-3193.
10. Boissier M.C., Chiocchia G., Bessis N., Hajnal J., Garotta G., Nicoletti F., et al. Biphasic effect of interferon-gamma in murine collagen-induced arthritis. Eur J Immunol 1995, 25:1184-1190.
11. Nakajima H., Takamori H., Hiyama Y., Tsukada W. The effect of treatment with interferon-gamma on type II collagen-induced arthritis. Clin Exp Immunol 1990, 81:441-445.
12. Williams R.O., Williams D.G., Feldmann M., Maini R.N. Increased limb involvement in murine collagen-induced arthritis following treatment with anti-interferon-gamma. Clin Exp Immunol 1993, 92:323-327.
13. Murphy C.A., Langrish C.L., Chen Y., Blumenschein W., McClanahan T., Kastelein R.A., et al. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J Exp Med 2003, 198:1951-1957.
14. Tesmer L.A., Lundy S.K., Sarkar S., Fox D.A. Th17 cells in human disease. Immunol Rev 2008, 223:87-113.
15. Yen D., Cheung J., Scheerens H., Poulet F., McClanahan T., McKenzie B., et al. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest 2006, 116:1310-1316.
16. Zheng Y., Danilenko D.M., Valdez P., Kasman I., Eastham-Anderson J., Wu J., et al. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 2007, 445:648-651.
17. Aarvak T., Chabaud M., Miossec P., Natvig J.B. IL-17 is produced by some proinflammatory Th1/Th0 cells but not by Th2 cells. J Immunol 1999, 162:1246-1251.
18. Hwang S.Y., Kim H.Y. Expression of IL-17 homologs and their receptors in the synovial cells of rheumatoid arthritis patients. Mol Cells 2005, 19:180-184.
19. Kirkham B.W., Lassere M.N., Edmonds J.P., Juhasz K.M., Bird P.A., Lee C.S., et al. Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: a two-year prospective study (the DAMAGE study cohort). Arthritis Rheum 2006, 54:1122-1131.
20. Ziolkowska M., Koc A., Luszczykiewicz G., Ksiezopolska-Pietrzak K., Klimczak E., Chwalinska-Sadowska H., et al. High levels of IL-17 in rheumatoid arthritis patients: IL-15 triggers in vitro IL-17 production via cyclosporin A-sensitive mechanism. J Immunol 2000, 164:2832-2838.
21. Guedez Y.B., Whittington K.B., Clayton J.L., Joosten L.A., van de Loo F.A., van den Berg W.B., et al. Genetic ablation of interferon-gamma up-regulates interleukin-1beta expression and enables the elicitation of collagen-induced arthritis in a nonsusceptible mouse strain. Arthritis Rheum 2001, 44:2413-2424.
22. Nakae S., Nambu A., Sudo K., Iwakura Y. Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J Immunol 2003, 171:6173-6177.
23. Nakae S., Saijo S., Horai R., Sudo K., Mori S., Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A 2003, 100:5986-5990.
24. Lubberts E., Koenders M.I., Oppers-Walgreen B., van den Bersselaar L., Coenen-de Roo C.J., Joosten L.A., et al. Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion. Arthritis Rheum 2004, 50:650-659.
25. Latham K.A., Whittington K.B., Zhou R., Qian Z., Rosloniec E.F. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints. J Immunol 2005, 174:3978-3985.
26. Koenders M.I., Lubberts E., Oppers-Walgreen B., van den Bersselaar L., Helsen M.M., Di Padova F.E., et al. Blocking of interleukin-17 during reactivation of experimental arthritis prevents joint inflammation and bone erosion by decreasing RANKL and interleukin-1. Am J Pathol 2005, 167:141-149.
27. Lubberts E., Schwarzenberger P., Huang W., Schurr J.R., Peschon J.J., van den Berg W.B., et al. Requirement of IL-17 receptor signaling in radiation-resistant cells in the joint for full progression of destructive synovitis. J Immunol 2005, 175:3360-3368.
28. Hirota K., Hashimoto M., Yoshitomi H., Tanaka S., Nomura T., Yamaguchi T., et al. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 2007, 204:41-47.
29. Chu C.Q., Swart D., Alcorn D., Tocker J., Elkon K.B. Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum 2007, 56:1145-1151.
30. Cao Y., Doodes P.D., Glant T.T., Finnegan A. IL-27 induces a Th1 immune response and susceptibility to experimental arthritis. J Immunol 2008, 180:922-930.
31. Doodes P.D., Cao Y., Hamel K.M., Wang Y., Farkas B., Iwakura Y., et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008, 181:329-337.
32. Finnegan A., Grusby M.J., Kaplan C.D., O'Neill S.K., Eibel H., Koreny T., et al. IL-4 and IL-12 regulate proteoglycan-induced arthritis through Stat-dependent mechanisms. J Immunol 2002, 169:3345-3352.
33. Iwanami K., Matsumoto I., Tanaka-Watanabe Y., Inoue A., Mihara M., Ohsugi Y., et al. Crucial role of the interleukin-6/interleukin-17 cytokine axis in the induction of arthritis by glucose-6-phosphate isomerase. Arthritis Rheum 2008, 58:754-763.
34. Jacobs J.P., Wu H.J., Benoist C., Mathis D. IL-17-producing T cells can augment autoantibody-induced arthritis. Proc Natl Acad Sci U S A 2009, 106:21789-21794.
35. Wu H.J., Ivanov I.I., Darce J., Hattori K., Shima T., Umesaki Y., et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity 2010, 32:815-827.
36. Mitsdoerffer M., Lee Y., Jager A., Kim H.J., Korn T., Kolls J.K., et al. Proinflammatory T helper type 17 cells are effective B-cell helpers. Proc Natl Acad Sci U S A 2010, 107:14292-14297.
37. LaBranche T.P., Hickman-Brecks C.L., Meyer D.M., Storer C.E., Jesson M.I., Shelvin K.M., et al. Characterization of the KRN cell transfer model of rheumatoid arthritis (KRN-CTM), a chronic yet synchronized version of the K/BxN mouse. Am J Pathol 2010, 177:1388-1396.
38. Mombaerts P., Clarke A.R., Rudnicki M.A., Iacomini J., Itohara S., Lafaille J.J., et al. Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature 1992, 360:225-231.
39. Lohoff M., Duncan G.S., Ferrick D., Mittrucker H.W., Bischof S., Prechtl S., et al. Deficiency in the transcription factor interferon regulatory factor (IRF)-2 leads to severely compromised development of natural killer and T helper type 1 cells. J Exp Med 2000, 192:325-336.
40. Stockinger B., Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 2007, 19:281-286.
41. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
42. Shih F.F., Mandik-Nayak L., Wipke B.T., Allen P.M. Massive thymic deletion results in systemic autoimmunity through elimination of CD4+ CD25+ T regulatory cells. J Exp Med 2004, 199:323-335.
43. Mandik-Nayak L., Wipke B.T., Shih F.F., Unanue E.R., Allen P.M. Despite ubiquitous autoantigen expression, arthritogenic autoantibody response initiates in the local lymph node. PNAS 2002, 99:14368-14373.
44. Lafaille J.J., Keere F.V., Hsu A.L., Baron J.L., Haas W., Raine C.S., et al. Myelin basic protein-specific T helper 2 (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease. J Exp Med 1997, 186:307-312.
45. Pakala S.V., Kurrer M.O., Katz J.D. T helper 2 (Th2) T cells induce acute pancreatitis and diabetes in immune-compromised nonobese diabetic (NOD) mice. J Exp Med 1997, 186:299-306.
46. Shi G., Cox C.A., Vistica B.P., Tan C., Wawrousek E.F., Gery I. Phenotype switching by inflammation-inducing polarized Th17 cells, but not by Th1 cells. J Immunol 2008, 181:7205-7213.
47. Webb A., Johnson A., Fortunato M., Platt A., Crabbe T., Christie M.I., et al. Evidence for PI-3K-dependent migration of Th17-polarized cells in response to CCR2 and CCR6 agonists. J Leukoc Biol 2008, 84:1202-1212.
48. Yang Y., Weiner J., Liu Y., Smith A.J., Huss D.J., Winger R., et al. T-bet is essential for encephalitogenicity of both Th1 and Th17 cells. J Exp Med 2009, 206:1549-1564.
49. Mukasa R., Balasubramani A., Lee Y.K., Whitley S.K., Weaver B.T., Shibata Y., et al. Epigenetic instability of cytokine and transcription factor gene loci underlies plasticity of the T helper 17 cell lineage. Immunity 2010, 32:616-627.
50. Korn T., Bettelli E., Oukka M., Kuchroo V.K. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517.
51. Maccioni M., Zeder-Lutz G., Huang H., Ebel C., Gerber P., Hergueux J., et al. Arthritogenic monoclonal antibodies from K/BxN mice. J Exp Med 2002, 195:1071-1077.
52. Ey P.L., Prowse S.J., Jenkin C.R. Isolation of pure IgG1, IgG2a and IgG2b immunoglobulins from mouse serum using protein A-sepharose. Immunochemistry 1978, 15:429-436.
53. Bending D., De La Pena H., Veldhoen M., Phillips J.M., Uyttenhove C., Stockinger B., et al. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J Clin Invest 2009, 119:565-572.
54. Manoury-Schwartz B., Chiocchia G., Bessis N., Abehsira-Amar O., Batteux F., Muller S., et al. High susceptibility to collagen-induced arthritis in mice lacking IFN-gamma receptors. J Immunol 1997, 158:5501-5506.
55. Vermeire K., Heremans H., Vandeputte M., Huang S., Billiau A., Matthys P. Accelerated collagen-induced arthritis in IFN-gamma receptor-deficient mice. J Immunol 1997, 158:5507-5513.
56. Harrington L.E., Hatton R.D., Mangan P.R., Turner H., Murphy T.L., Weaver C.T. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005, 11:1123-1132.
57. Takayanagi H., Ogasawara K., Hida S., Chiba T., Murata S., Sato K., et al. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma. Nature 2000, 408:600-605.
58. Hofstetter H.H., Ibrahim S.M., Koczan D., Kruse N., Weishaupt A., Toyka K.V., et al. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol 2005, 237:123-130.
59. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 201:233-240.
60. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
61. Gaffen S.L., Kramer J.M., Yu J.J., Shen F. The IL-17 cytokine family. Vitam Horm 2006, 74:255-282.
62. Cua D.J., Sherlock J., Chen Y., Murphy C.A., Joyce B., Seymour B., et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003, 421:744-748.
63. Elson C.O., Cong Y., Weaver C.T., Schoeb T.R., McClanahan T.K., Fick R.B., et al. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice. Gastroenterology 2007, 132:2359-2370.
64. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 2007, 26:371-381.
65. Guo S., Cobb D., Smeltz R.B. T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. J Immunol 2009, 182:6179-6186.
66. Bai Y., Liu R., Huang D., La Cava A., Tang Y.Y., Iwakura Y., et al. CCL2 recruitment of IL-6-producing CD11b+ monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 2008, 38:1877-1888.
67. Lebman D.A., Edmiston J.S. The role of TGF-beta in growth, differentiation, and maturation of B lymphocytes. Microbes Infect 1999, 1:1297-1304.
68. McIntyre T.M., Klinman D.R., Rothman P., Lugo M., Dasch J.R., Mond J.J., et al. Transforming growth factor B1 selectivity stimulates Immunoglobulin G2b secretion by lipopolysaccharide-activted murine B cells. J Exp Med 1993, 177:1031-1037.
69. Kishimoto T. B-cell stimulatory factors (BSFs): molecular structure, biological function, and regulation of expression. J Clin Invest 1987, 5:343-355.